Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity

AIM: Obesity is a disease complicating the course of COVID-19 and SARS-CoV-2 vaccine effectiveness in adults with obesity may be compromised. Our aim is to investigate the spike-protein receptor-binding domain antibody titers against BNT162b2 mRNA and inactivated SARS-CoV-2 (CoronaVac) vaccines in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kara, Zehra, Akçin, Rüveyda, Demir, Ahmet Numan, Dinç, Harika Öykü, Taşkın, Halit Eren, Kocazeybek, Bekir, Yumuk, Volkan Demirhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263798/
https://www.ncbi.nlm.nih.gov/pubmed/35802279
http://dx.doi.org/10.1007/s11695-022-06181-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263798/
https://www.ncbi.nlm.nih.gov/pubmed/35802279
http://dx.doi.org/10.1007/s11695-022-06181-y

Ejemplares similares